Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast... oral placebo, afimoxifene, tamoxifen citrate, placebo gel NCT00952731 Northwestern University Completed
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention NCT00983580 National Cancer Institute (NCI) Active, not recruiting
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Aspirin, Laboratory Biomarker Analysis, Placebo NCT02169271 National Cancer Institute (NCI) Active, not recruiting
Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer acolbifene hydrochloride NCT00853996 University of Kansas Medical Center Completed
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing... Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study, Placebo NCT02917629 National Cancer Institute (NCI) Recruiting
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery NCT02598557 National Cancer Institute (NCI) Recruiting
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer atorvastatin calcium, laboratory biomarker analysis NCT00637481 National Cancer Institute (NCI) Completed
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers Aspirin, Laboratory Biomarker Analysis, Placebo, Zileuton NCT02348203 National Cancer Institute (NCI) Active, not recruiting
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer acetylsalicylic acid, placebo, laboratory biomarker analysis NCT00468910 National Cancer Institute (NCI) Completed

Pages